{"id":22805,"date":"2022-04-05T13:01:22","date_gmt":"2022-04-05T12:01:22","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=22805"},"modified":"2022-04-05T13:01:26","modified_gmt":"2022-04-05T12:01:26","slug":"spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/","title":{"rendered":"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables"},"content":{"rendered":"\n

Article publi\u00e9 sur Lesechos.fr<\/a> le 1er avril 2022<\/p>\n\n\n\n

Depuis le d\u00e9but de l’ann\u00e9e, la start-up strasbourgeoise Spartha Medical a obtenu plus de trois millions d’euros d’aides publiques pour poursuivre le d\u00e9veloppement de ses rev\u00eatements antimicrobiens, anti-inflammatoires et antiviraux d\u00e9di\u00e9s aux dispositifs m\u00e9dicaux, qui peuvent \u00eatre personnalis\u00e9s en fonction du profil immunitaire des patients. <\/p>\n\n\n\n

En janvier, le Conseil europ\u00e9en de l’innovation (EIC) lui a accord\u00e9 2,4\u00a0millions d’euros, compl\u00e9t\u00e9s au mois de mars par plus de 900.000\u00a0euros en subventions et avances remboursables de Bpifrance dans le cadre du\u00a0plan deeptech<\/a>.<\/p>\n\n\n\n

Ce spin-off de l’Inserm se fonde sur un brevet associant des mol\u00e9cules de polyarginine \u00e0 de l’acide hyaluronique. Leurs structures chimiques, dou\u00e9es d’une propension \u00e0 accumuler des charges \u00e9lectrostatiques, perturbent les membranes des cellules bact\u00e9riennes tout en restant inoffensives pour les cellules humaines. S’y ajoute une activit\u00e9 anti-inflammatoire de l’acide hyaluronique, pr\u00e9cise Baptiste Letellier, responsable des projets collaboratifs.<\/p>\n\n\n\n

Effet \u00ab aimant \u00bb<\/h3>\n\n\n\n

\u00ab\u00a0L’int\u00e9gration du m\u00e9lange peut se faire notamment par le biais de ces charges, permettant d’obtenir un effet ‘aimant” sur tout type de support\u00a0\u00bb, explique-t-il. \u00c0 la cl\u00e9, une int\u00e9gration \u00e0 des dispositifs tels les implants, ou encore \u00e0 des textiles m\u00e9dicaux comme les pansements. <\/p>\n\n\n\n

Parmi les applications de ces rev\u00eatements, la start-up compte aussi un pistolet d\u00e9di\u00e9 \u00e0 la cicatrisation et au soin des plaies, pour lequel des essais cliniques devraient commencer dans deux ans \u00e0 Strasbourg.<\/p>\n\n\n\n

Une lev\u00e9e de fonds de s\u00e9rie A \u00e0 hauteur de 3\u00a0millions \u00e0 5\u00a0millions d’euros est d’ailleurs \u00ab\u00a0en train de commencer\u00a0\u00bb pour financer un essai clinique plus \u00e9tendu, annonce Nihal Engin Vrana, pr\u00e9sident-directeur g\u00e9n\u00e9ral de Spartha Medical. <\/p>\n\n\n\n

En parall\u00e8le, l’entreprise poursuit ses recherches sur une d\u00e9clinaison grand public, qui prendrait la forme d’un spray biocompatible destin\u00e9 \u00e0 l’hygi\u00e8ne personnelle et \u00e0 la d\u00e9sinfection des surfaces au quotidien.<\/p>\n\n\n\n

La formulation est pr\u00eate et en cours de brevetage, reste \u00e0 obtenir l’autorisation pour sa commercialisation. Une d\u00e9marche\u00a0plus longue qu’attendu<\/a>, qui devrait encore prendre deux ans pour que les mol\u00e9cules exploit\u00e9es soient enregistr\u00e9es par l’Agence europ\u00e9enne des produits chimiques et que son innocuit\u00e9 soit d\u00e9montr\u00e9e.<\/p>\n\n\n\n

LA STRAT\u00c9GIE<\/h3>\n\n\n\n

Spartha Medical<\/h4>\n\n\n\n

Date de cr\u00e9ation : <\/strong>2019<\/p>\n\n\n\n

PDG : <\/strong>Nihal Engin Vrana<\/p>\n\n\n\n

Effectif : <\/strong>8 personnes<\/p>\n\n\n\n

Secteur : <\/strong>biotechnologies<\/p>\n","protected":false},"excerpt":{"rendered":"

Article publi\u00e9 sur Lesechos.fr le 1er avril 2022 Depuis le d\u00e9but de l’ann\u00e9e, la start-up strasbourgeoise Spartha Medical a obtenu plus de trois millions d’euros d’aides publiques pour poursuivre le d\u00e9veloppement de ses rev\u00eatements antimicrobiens, anti-inflammatoires et antiviraux d\u00e9di\u00e9s aux dispositifs m\u00e9dicaux, qui peuvent \u00eatre personnalis\u00e9s en fonction du profil immunitaire des patients. En janvier, […]<\/p>\n","protected":false},"author":139,"featured_media":22811,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"\nSpartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-05T12:01:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-05T12:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"619\" \/>\n\t<meta property=\"og:image:height\" content=\"497\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables\",\"datePublished\":\"2022-04-05T12:01:22+00:00\",\"dateModified\":\"2022-04-05T12:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\"},\"wordCount\":402,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\",\"name\":\"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg\",\"datePublished\":\"2022-04-05T12:01:22+00:00\",\"dateModified\":\"2022-04-05T12:01:26+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg\",\"width\":619,\"height\":497,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/","og_locale":"en_GB","og_type":"article","og_title":"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-04-05T12:01:22+00:00","article_modified_time":"2022-04-05T12:01:26+00:00","og_image":[{"width":619,"height":497,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables","datePublished":"2022-04-05T12:01:22+00:00","dateModified":"2022-04-05T12:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/"},"wordCount":402,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/","name":"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg","datePublished":"2022-04-05T12:01:22+00:00","dateModified":"2022-04-05T12:01:26+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/04\/Desinfection.jpg","width":619,"height":497,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/spartha-medical-finance-ses-revetements-antimicrobiens-et-antiviraux-personnalisables\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Spartha Medical finance ses rev\u00eatements antimicrobiens et antiviraux personnalisables"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-13 19:37:17","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/22805"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=22805"}],"version-history":[{"count":6,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/22805\/revisions"}],"predecessor-version":[{"id":22821,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/22805\/revisions\/22821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/22811"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=22805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=22805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=22805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}